Related Experiment Video

Updated: May 9, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

MC1R and cAMP signaling inhibit cdc25B activity and delay cell cycle progression in melanoma cells

Jesse Lyons1, Boris C Bastian, Frank McCormick

  • 1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA.

Proceedings of the National Academy of Sciences of the United States of America
|August 3, 2013
PubMed

Insights

Melanocortin 1 receptor (MC1R) signaling directly inhibits melanoma cell growth by delaying cell cycle progression. This pathway regulates the G2/M checkpoint, offering a potential new target for melanoma treatment.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Dermatology

Background:

  • The melanocortin 1 receptor (MC1R) is crucial for skin tanning and is linked to melanoma risk.
  • Reduced MC1R function is associated with decreased tanning and higher mutation rates, potentially increasing melanoma susceptibility.

Purpose of the Study:

  • To investigate the direct effects of MC1R and cAMP signaling on melanoma cell proliferation.
  • To elucidate the molecular mechanisms by which MC1R signaling impacts melanoma cell cycle progression.

Main Methods:

  • Utilized melanoma cell lines with MC1R overexpression and ligand treatment.
  • Administered small-molecule activators of cAMP signaling.
  • Analyzed cell cycle progression, focusing on the G2/M checkpoint and cdc25B phosphorylation.

Main Results:

  • MC1R or cAMP signaling directly inhibited melanoma cell proliferation.
  • MC1R activation delayed melanoma cell progression from G2 into mitosis.
  • This delay was mediated by the phosphorylation and inhibition of cdc25B, a key regulator of the G2/M transition.

Conclusions:

  • MC1R and cAMP signaling possess direct anti-proliferative effects on melanoma cells.
  • Regulation of the G2/M checkpoint via cdc25B inhibition is a key mechanism of MC1R's anti-melanoma activity.
  • Targeting MC1R or cAMP pathways may offer novel therapeutic strategies for melanoma.
Keywords:
g-protein coupled receptorsgenetic risk factorsskin cancer

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...